TRIAL DETAIL
MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery |
|||
NCT#: |
||||
Conditions: |
Sarcoma |
|||
Status: |
Ongoing, but not recruiting |
|||
Phase: |
2 |
Start Date 10/01/2010 |
Age of Trial (yrs) 14.2 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
mTOR inhibitor + MEK inhibitor |
|||
Strategy: |
||||
Trial Type: |
GIST not specified. GIST patients known to be enrolled. |
|||
Other Protocol IDs: |
CDR0000685408, CHNMC-PHII-95, NCCN-T06 |
|||
Sponsor: |
Beckman Research Institute,National Cancer Institute (NCI),
National Comprehensive Cancer Network |
|||
Patient Contact: |
||||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
9090 Wilshire Blvd |
Beverly Hills |
CA |
90211 |
USA |
|
1500 E. Duarte Road |
Duarte |
CA |
91010 |
USA |
|
Los Angeles |
CA |
90089 |
USA |
||
Pasadena |
CA |
91105 |
USA |
||
Hershey |
PA |
17033 |
USA |
||
Pittsburgh |
PA |
15232 |
USA |
||
4501 X St |
Sacramento |
CA |
95817 |
USA |